318 related articles for article (PubMed ID: 25689245)
1. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
Oghazian MB; Javadi MR; Radfar M; Torkamandi H; Sadeghi M; Hayatshahi A; Gholami K
Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
[TBL] [Abstract][Full Text] [Related]
2. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
Hakeam HA; Mulia HA; Azzam A; Amin T
JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
[TBL] [Abstract][Full Text] [Related]
3. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management.
Jakoby MG; Nannapaneni N
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2):183-8. PubMed ID: 21825091
[TBL] [Abstract][Full Text] [Related]
4. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
Yeldandi RR; Lurie A; Baldwin D
Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
[TBL] [Abstract][Full Text] [Related]
6. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
[TBL] [Abstract][Full Text] [Related]
7. Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.
Silinskie KM; Kirshner R; Hite MS
Ann Pharmacother; 2013 Jan; 47(1):20-8. PubMed ID: 23324510
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition.
Pasquel FJ; Smiley D; Spiegelman R; Lin E; Peng L; Umpierrez GE
Hosp Pract (1995); 2011 Apr; 39(2):81-8. PubMed ID: 21576900
[TBL] [Abstract][Full Text] [Related]
9. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.
Saur NM; Kongable GL; Holewinski S; O'Brien K; Nasraway SA
Mayo Clin Proc; 2013 Sep; 88(9):920-9. PubMed ID: 24001484
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition.
Pleva M; Mirtallo JM; Steinberg SM
Nutr Clin Pract; 2009; 24(5):626-34. PubMed ID: 19564627
[TBL] [Abstract][Full Text] [Related]
11. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.
Bernard JB; Munoz C; Harper J; Muriello M; Rico E; Baldwin D
J Hosp Med; 2011 May; 6(5):279-84. PubMed ID: 21661100
[TBL] [Abstract][Full Text] [Related]
12. [Management of blood glucose during enteral nutrition in critical patients].
Liu Y; He W; Zhou H; Li T; Xu Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Sep; 24(9):546-9. PubMed ID: 22938664
[TBL] [Abstract][Full Text] [Related]
13. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
[TBL] [Abstract][Full Text] [Related]
14. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
[TBL] [Abstract][Full Text] [Related]
15. Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition.
Ramos A; Zapata L; Vera P; Betbese AJ; Pérez A
Endocrinol Diabetes Nutr; 2017 Dec; 64(10):552-556. PubMed ID: 29179857
[TBL] [Abstract][Full Text] [Related]
16. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
Fox MA; Perry MC; Liu-DeRyke X
Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition.
Yan CL; Huang YB; Chen CY; Huang GS; Yeh MK; Liaw WJ
Acta Anaesthesiol Taiwan; 2013 Jun; 51(2):67-72. PubMed ID: 23968657
[TBL] [Abstract][Full Text] [Related]
18. Insulin glargine dosing before next-day surgery: comparing three strategies.
Rosenblatt SI; Dukatz T; Jahn R; Ramsdell C; Sakharova A; Henry M; Arndt-Mutz M; Miller V; Rogers K; Balasubramaniam M
J Clin Anesth; 2012 Dec; 24(8):610-7. PubMed ID: 23122972
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
[TBL] [Abstract][Full Text] [Related]
20. Insulin glargine in patients with severe hepato-gastroenterology diseases and hyperglycemia receiving parenteral nutrition.
Fatati G; Mirri E; Palazzi M; Vendetti AL; Pierotti F; Weber P; Mattei R; Parillo M; Coaccioli S; Puxeddu A
Clin Ter; 2006; 157(6):511-5. PubMed ID: 17228850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
